| For: | Dung PT, Su HX, Tue NC, Ben NH, Phuong NM, Tran TN, Nghia PB, Van DT, Dung NTT, Vinh HT, Rostaing L, Toan PQ. Predictive value of tacrolimus concentration/dose ratio in first post-transplant week for CYP3A5-polymorphism in kidney-transplant recipients. World J Transplant 2025; 15(2): 103247 [PMID: 40535494 DOI: 10.5500/wjt.v15.i2.103247] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v15/i2/103247.htm |
| Number | Citing Articles |
| 1 |
Anders Larsson, Johan Saldeen, Jonathan Cedernaes, Mats B. Eriksson, Mathias Karlsson, Anna-Karin Hamberg. Decreasing Tacrolimus Concentrations in Routine Therapeutic Drug Monitoring Data Indicate Adherence to Updated Therapeutic Goals. Biomedicines 2026; 14(1) doi: 10.3390/biomedicines14010094
|
| 2 |
Andrea Guzmán-de Antonio, Carlos Jiménez-Martín, Elia B. Márquez-Cabello, Marcos Navares-Gómez, María O. López-Oliva, Elena González-García, Lucía Díaz-García, Rocío Rosas-Alonso, Irene García-García, Alberto M. Borobia, Antonio J. Carcas. Integrating pharmacogenetic and clinical factors to predict the C0/D/W-based tacrolimus phenotype in kidney transplantation. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1772820
|
| 3 |
Yohei Abe, Takuma Kato, Asuka Kaji, Satoshi Harada, Kengo Fujiwara, Kana Kohashiguchi, Hirohito Naito, Yoichiro Tohi, Homare Okazoe, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto. Association Between Early Perioperative Fentanyl Exposure and Dose-Normalized Tacrolimus Exposure After Kidney Transplantation. Progress in Transplantation 2026; doi: 10.1177/15269248261486978
|
| 4 |
Manman Liu, Lan Li, Chen Zhou, Changying Luo, Xiaodong Wang, Juan Wu. Case Report: Pediatric isavuconazole supratherapeutic exposure: a case of long-term use, CYP3A5 poor metabolizer genotype and concomitant CYP3A4 medications. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1807350
|